However, this yeast has some very distinctive staining characteristics that distinguish it from other microorganisms. It stains positively with the Gram stain, but unlike bacteria in which the stain is found in the cell walls, the stain variably accumulates in the cytoplasm of M. ornithogaster and is not found in the cell wall. The yeast also stains with the Periodic Acid Shift stain and the positive response obtained with calcafl uor distinguishes it from bacteria [1]. Genetically, it is readily separated from bacteria, as its ribosomal DNA can be amplifi ed by PCR using panfungal and M. ornithogaster -specifi c primers [1].
Introduction
Macrorhabdus ornithogaster (formally known as megabacteria) is an anamorphic ascomycetous yeast. Based on phylogenetic analysis of its rDNA it is the only known member of its genus and is only distantly related to other yeasts [1] . It commonly infects budgerigars and canaries, as well as several other species of psittacine and passerine birds, ostriches and chickens. M. ornithogaster grows exclusively on the mucosal surface of the junction of the proventriculus and ventriculus (gastric isthmus) (Fig. 1) . Most infections do not result in overt manifestations, but mild infl ammatory lesions are seen histologically in clinically normal birds and a chronic wasting disease and an acute hemorrhagic gastritis are occasionally associated with infection [2] .
M. ornithogaster is a slender and long microorganism (2 μ m wide and up to 80 μ m long) composed of two to six cells (Fig. 2) [1]. Filamentous bacteria and chains of large rod-shaped bacteria can superfi cially resemble it. stomach of mice [4] . However, genomic analysis of this organism subsequently showed it to be a bacterium and not M. ornithogaster (Phalen, D.N. unpublished observation 2005) .
M. ornithogaster is fastidious and has only recently been grown in vitro . To grow, it requires a microaerophilic environment and a liquid or semi-solid media of pH 3 -4 containing bovine serum and one of several sugars. The yeast optimally grows at 42 ° C, somewhat more slowly at 37 ° C, and does not grow at room temperature [5] . Given that M. ornithogaster requires such restricted growth conditions, it is unlikely that the organisms seen in the respiratory secretions of the dog and cat were this microorganism.
The ability to culture M. ornithogaster has created an opportunity to perform controlled infection trials with pure preparations of organisms. The purpose of the study reported here was to test the hypothesis that M. ornithogaster can infect a mammalian species, the mouse.
Materials and methods
Fifteen 10-week-old outbred albino mice (Animal Resoruce Centre, Canning Vale, Western Australia) (S) mice were included in this study. Mice were housed in standard isolation units in a temperature controlled room and provided with food and water ad libitum . The study protocol was reviewed and approved by the University of Sydney ' s Animal Ethics Committee.
Macrorhabdus ornithogaster was grown, as previously described, from scrapings of the gastric isthmus of a budgerigar ( Melospittacus undulates ) that died spontaneously with an ulcerative proventriculitis [5] . Briefl y, scrapings from the gastric isthmus were inoculated into Basal Eagle ' s Medium, pH 3.5, containing 20% fetal bovine serum, 2% glucose and 100 IU/ ml of each penicillin and streptomycin and incubated at 42 ° C in a microaerophilic environment. Growth of the fungus was immediate and robust and 10-fold dilutions were made every third day. The fi fth passage of this isolate was used in the infection trial. Organisms were incubated for 4 days between passages. The fi fth passage was used as it was the fi rst to generate suffi cient organisms to use in the infection trials. Immediately prior to inoculation, the concentration of M. ornithogaster was determined by counting organisms in a haemocytometer. Macrorhabdus ornithogaster forms rods that contain between 1 and 4 nuclei. A single rod was considered as an organism in this study. Organisms were then pelleted (1000 g for 1 min) and resuspended in 0.25 ml of phosphate-buffered saline (PBS) (pH 7.4). Mice were randomly assigned to three treatment groups each containing fi ve animals. One million and 10 million organisms were given by gavage in 0.25 ml of PBS into the oesophagus of the fi rst ( n ϭ 5) and second ( n ϭ 5) treatment groups of mice. Ten million organisms were injected into the peritoneum of the third treatment group in a volume of 0.25 ml PBS ( n ϭ 5). The numbers of organisms used to inoculate the mice were chosen to maximize the chance that infection if it was possible would occur.
Each treatment group was monitored for the fi rst 2 h following inoculation and then daily for 5 days. On the 5th day, animals were humanely euthanized as this was the day that experimental chickens were found to be infected [6] . Heart, lung, liver, spleen, kidney, oesophagus, stomach, peritoneum, mesentery, duodenum, higher than the minimum dosage that caused 100% infection after fi ve days in day-old chickens and therefore could be expected to result in infection in the mice [7] . These doses were chosen to provide the maximum opportunity for infection and yet still be in a range that would result in 100% infection in chickens (Phalen, unpublished observation, 2004) . Given that infection did not occur we conclude that gastric infection of simple stomach mammals and systemic infection of mammals by M. ornithogaster is either unlikely or impossible. We cannot completely rule out that had we used immunodefi cient (nude) mice that infection would have been possible. However, we consider it unlikely, as the 5 days period between inoculation and apparent complete clearance of the organism would be too short for infection to have been mediated by an acquired immune response. Thus, we consider it more likely that environmental conditions such as oxygen, hydrogen ion, or nutrient concentrations where more likely to have prevented infection.
A chronic interstitial pneumonia was found in three mice but Macrorhabdus ornithogaster was not found in these lesions. Similar lesions can be caused by the murine pneumonvirus, Sendai virus, Mycoplasma pulmonis and Chlamydia muridarum . Potentially any one of these could be found in laboratory mice [10] . Given that these lesions were chronic and likely to have been present at the time of the infection we feel that they were unrelated to the treatment trial. 
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